"Granulocyte Colony-Stimulating Factor/therapeutic use"[MeSH Terms] - Search Results

Year	Number of Results
1989	1
1990	52
1991	124
1992	191
1993	318
1994	401
1995	463
1996	444
1997	474
1998	464
1999	362
2000	388
2001	336
2002	338
2003	319
2004	279
2005	312
2006	375
2007	323
2008	313
2009	332
2010	322
2011	362
2012	319
2013	305
2014	337
2015	301
2016	265
2017	280
2018	242
2019	265
2020	240
2021	204
2022	196
2023	166
2024	65

1

A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.

Dale DC, Crawford J, Klippel Z, Reiner M, Osslund T, Fan E, Morrow PK, Allcott K, Lyman GH. Dale DC, et al. Support Care Cancer. 2018 Jan;26(1):7-20. doi: 10.1007/s00520-017-3854-x. Epub 2017 Sep 22. Support Care Cancer. 2018. PMID: 28939926 Free PMC article. Review.

2

Use of granulocyte colony-stimulating factor for adult cancer patients: current issues and future directions.

Rizzo A. Rizzo A. Future Oncol. 2021 Sep;17(26):3411-3413. doi: 10.2217/fon-2021-0678. Epub 2021 Jul 15. Future Oncol. 2021. PMID: 34263652 No abstract available.

3

Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF).

Link H. Link H. Support Care Cancer. 2022 Sep;30(9):7067-7077. doi: 10.1007/s00520-022-07103-5. Support Care Cancer. 2022. PMID: 35739328 Free PMC article. No abstract available.

4

The effects of granulocyte-colony stimulating factor on chronic liver disease: a meta-analysis.

Shi P, Zhang J, Wu M, Zheng T, Liang A, Wen Z, Wu X. Shi P, et al. J Infect Dev Ctries. 2022 Mar 31;16(3):537-546. doi: 10.3855/jidc.14961. J Infect Dev Ctries. 2022. PMID: 35404861 Free article.

5

Motixafortide: First Approval.

Hoy SM. Hoy SM. Drugs. 2023 Nov;83(17):1635-1643. doi: 10.1007/s40265-023-01962-w. Drugs. 2023. PMID: 37996648 Review.

6

Granulocyte colony-stimulating factor.

Kaptan K, Beyan C, Ifran A. Kaptan K, et al. CMAJ. 2006 Oct 24;175(9):1095; author reply 1095-6. doi: 10.1503/cmaj.1060064. CMAJ. 2006. PMID: 17060662 Free PMC article. No abstract available.

7

Granulocyte colony-stimulating factor administration: adverse events.

D'Souza A, Jaiyesimi I, Trainor L, Venuturumili P. D'Souza A, et al. Transfus Med Rev. 2008 Oct;22(4):280-90. doi: 10.1016/j.tmrv.2008.05.005. Transfus Med Rev. 2008. PMID: 18848155 Review.

8

Granulocyte colony stimulating factor therapy for acute myocardial infarction.

Moazzami K, Roohi A, Moazzami B. Moazzami K, et al. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008844. doi: 10.1002/14651858.CD008844.pub2. Cochrane Database Syst Rev. 2013. PMID: 23728682 Free PMC article. Review.

9

Granulocyte colony-stimulating factor for the treatment of cardiovascular diseases: An update with a critical appraisal.

D'Amario D, Leone AM, Borovac JA, Cannata F, Siracusano A, Niccoli G, Crea F. D'Amario D, et al. Pharmacol Res. 2018 Jan;127:67-76. doi: 10.1016/j.phrs.2017.06.001. Epub 2017 Jun 7. Pharmacol Res. 2018. PMID: 28602846 Review.

10

Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis.

Rathi S, Hussaini T, Yoshida EM. Rathi S, et al. Ann Hepatol. 2021 Jan-Feb;20:100211. doi: 10.1016/j.aohep.2020.04.011. Epub 2020 Jun 6. Ann Hepatol. 2021. PMID: 32533952 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9,639 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9,639 results

Results by year